XML 47 R36.htm IDEA: XBRL DOCUMENT v3.24.3
Revenue Recognition - Schedule of Drug Revenue Recognition (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Disaggregation Of Revenue [Line Items]        
Total drug discovery revenue $ 3,406 $ 13,665 $ 18,519 $ 52,071
Drug discovery services revenue from contracts with customers        
Disaggregation Of Revenue [Line Items]        
Total drug discovery revenue 2,813 12,730 17,012 49,765
Drug discovery contribution        
Disaggregation Of Revenue [Line Items]        
Total drug discovery revenue $ 593 $ 935 $ 1,507 $ 2,306